Literature DB >> 19220727

Health status and quality of life of elderly persons with severe hemophilia born before the advent of modern replacement therapy.

S M Siboni1, P M Mannucci, A Gringeri, M Franchini, A Tagliaferri, M Ferretti, F C Tradati, E Santagostino, S von Mackensen.   

Abstract

SUMMARY
BACKGROUND: More and more people with severe hemophilia reach an old age thanks to an effective treatment. There is no information on the health status and quality of life of elderly people with hemophilia born at a time when replacement therapy was hardly available.
METHODS: Italian patients with severe hemophilia, aged >or=65 years and hence born in 1942 or earlier, were compared with elderly men without bleeding disorders matched for age, sex, geography and social status. The following aspects were evaluated: concomitant illness, orthopedic status, physical functioning and cognitive status. Measurements of generic and disease-specific health-related quality of life were also obtained, together with the presence or absence of depression.
RESULTS: Thirty-nine patients, aged 65-78 years, were investigated; 33 had hemophilia A. All patients had started regular treatment on demand only when they were already 25-30 years of age. Patients were compared with 43 men without hemophilia, aged 65-79 years. More patients with hemophilia had chronic hepatitis B and C, HIV infection and hypertension. On the other hand, their elderly peers without hemophilia were more frequently hypercholesterolemic and had more cardiovascular diseases. Most hemophiliacs had arthropathy and worse values for physical functioning, but their cognitive status was similar to that of elderly non-hemophiliacs. Hemophiliacs reported greater depression and lower health-related quality of life.
CONCLUSIONS: Elderly patients with hemophilia have more co-morbidities and problems in daily living, but similar cognitive status as age-matched non-hemophilic peers. They have more chronic viral infections and hypertension but fewer cardiovascular diseases. These observations should help to optimize health care delivery in this increasing and neglected population of people with hemophilia.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19220727     DOI: 10.1111/j.1538-7836.2009.03318.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  18 in total

1.  Markers of Blood Cell Activation and Complement Activation in Factor VIII and von Willebrand Factor Concentrates.

Authors:  Martin F Brodde; Beate E Kehrel
Journal:  Transfus Med Hemother       Date:  2010-07-14       Impact factor: 3.747

2.  Atherosclerotic heart disease: prevalence and risk factors in hospitalized men with haemophilia A.

Authors:  M V Ragni; C G Moore
Journal:  Haemophilia       Date:  2011-03-04       Impact factor: 4.287

3.  Tailoring care to haemophilia patients' needs: which specialty and when?

Authors:  Massimo Morfini; Gary Benson; Victor Jiménez-Yuste; Rolf Ljung; Pier Mannuccio Mannucci; Gianluigi Pasta; Eduardo Remor; Silva Zupančić Šalek
Journal:  Blood Transfus       Date:  2015-05-20       Impact factor: 3.443

Review 4.  Management of Hemophilia in Older Patients.

Authors:  Massimo Franchini; Pier Mannuccio Mannucci
Journal:  Drugs Aging       Date:  2017-12       Impact factor: 3.923

5.  Prevalence and risk factors for hypertension in hemophilia.

Authors:  Annette von Drygalski; Nicholas A Kolaitis; Ricki Bettencourt; Jaclyn Bergstrom; R Kruse-Jarres; Doris V Quon; Christina Wassel; Ming C Li; Jill Waalen; Darlene J Elias; Laurent O Mosnier; Matthew Allison
Journal:  Hypertension       Date:  2013-04-29       Impact factor: 10.190

6.  A cross-sectional analysis of cardiovascular disease in the hemophilia population.

Authors:  Suman L Sood; Dunlei Cheng; Margaret Ragni; Craig M Kessler; Doris Quon; Amy D Shapiro; Nigel S Key; Marilyn J Manco-Johnson; Adam Cuker; Christine Kempton; Tzu-Fei Wang; M Elaine Eyster; Philip Kuriakose; Annette von Drygalski; Joan Cox Gill; Allison Wheeler; Peter Kouides; Miguel A Escobar; Cindy Leissinger; Sarah Galdzicka; Marshall Corson; Crystal Watson; Barbara A Konkle
Journal:  Blood Adv       Date:  2018-06-12

7.  Multiple Comorbid Conditions among Middle-Aged and Elderly Hemophilia Patients: Prevalence Estimates and Implications for Future Care.

Authors:  Aroub A Khleif; Nidra Rodriguez; Deborah Brown; Miguel A Escobar
Journal:  J Aging Res       Date:  2011-09-07

8.  A Cohort Pilot Study on HIV-Associated Neuropsychological Impairments in Hemophilia Patients.

Authors:  Silvia Riva; Ilaria Cutica; Caspar Krampe; Laura F Reinecke; William Russell-Edu; Cristina Santoro; Angiola Rocino; Elena Santagostino; Vega Rusconi; Gabriella Pravettoni
Journal:  Front Hum Neurosci       Date:  2015-06-02       Impact factor: 3.169

9.  Prophylaxis in older Canadian adults with hemophilia A: lessons and more questions.

Authors:  Shannon C Jackson; Ming Yang; Leonard Minuk; Michelle Sholzberg; Jean St-Louis; Alfonso Iorio; Robert Card; Man-Chiu Poon
Journal:  BMC Hematol       Date:  2015-02-14

10.  Psychological interventions for people with hemophilia.

Authors:  Laura Palareti; Giannino Melotti; Frederica Cassis; Sarah J Nevitt; Alfonso Iorio
Journal:  Cochrane Database Syst Rev       Date:  2020-03-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.